Table of Contents

Table of Contents

Featured Article

Understanding the Impact of COVID-19 on Corneal Transplant Need and Demand through the Example of Australia

Letter from Editor

Letter from the Editor

Research / Proceedings

Autopsy Final Report Findings and Corneal Transplantation: A Retrospective Review

Corneal Transplantation from Donors Serologically Positive for Trypanosoma cruzi

Alterations In the Measured Intraocular Pressure Following Corneal Collagen Cross Linking

Abstracts from 2020 Eye Bank Association of America Scientific Symposium

Letter from the Editor


Ellen Heck
Co-Editor in Chief


Cost Savings of Appropriate Screening of Potential Donors
Although a certain amount of recovered donated ocular tissue will, for one reason or another, ultimately be determined to be unsuitable for transplantation, minimizing this loss is important for many reasons. In the present day, the number of exclusions for risk of communicable diseases has been increasing. Hepatitis B, Hepatitis C, Syphilis and HIV have been joined by West Nile, COVID 19, and Zika. The loss of transplantable tissue can lead to the possible delay of a surgery and a patient’s expectation for improved vision, disappointment for the donor family; such losses also represent a financial burden to the eye bank. While most eye banks would consider the financial loss as the least important factor in their mission to restore sight, it is nevertheless a necessary consideration for the delivery of corneal tissues for transplantation, teaching, and research.

Article PDF

Fullscreen Mode